These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10649624)
21. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen. Xie Y; Sun HX; Li D Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358 [TBL] [Abstract][Full Text] [Related]
22. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Wen YM; Qu D; Zhou SH Int Rev Immunol; 1999; 18(3):251-8. PubMed ID: 10614727 [TBL] [Abstract][Full Text] [Related]
23. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463 [TBL] [Abstract][Full Text] [Related]
24. [Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice]. Jin YW; Li P; Xu QB; Liu X; Huang W; Wang YL; Cao C; Ma QJ Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):681-5. PubMed ID: 16285504 [TBL] [Abstract][Full Text] [Related]
25. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923 [TBL] [Abstract][Full Text] [Related]
26. Immune response induced by a different combined immunization of HBsAg vaccine. Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028 [TBL] [Abstract][Full Text] [Related]
27. T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides. Zhou X; Zheng L; Liu L; Xiang L; Yuan Z Scand J Immunol; 2003 Sep; 58(3):350-7. PubMed ID: 12950682 [TBL] [Abstract][Full Text] [Related]
28. Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice. Zhang G; Li X; Liu L; Li J; Chen Q; Huang S; Li Y; Wan X Biochem Biophys Res Commun; 2018 Oct; 504(4):865-870. PubMed ID: 30219230 [TBL] [Abstract][Full Text] [Related]
29. [Reciprocal priming-boosting role of HBsAg and DNA vaccines]. Zhou Z; Chen WS; Zhang HH; Yao JL Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517 [TBL] [Abstract][Full Text] [Related]
30. RLJ-NE-299A: a new plant based vaccine adjuvant. Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726 [TBL] [Abstract][Full Text] [Related]
31. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. Du DW; Jia ZS; Li GY; Zhou YY World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362 [TBL] [Abstract][Full Text] [Related]
32. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
33. Immune responses to hepatitis B surface antigen following epidermal powder immunization. Osorio JE; Zuleger CL; Burger M; Chu Q; Payne LG; Chen D Immunol Cell Biol; 2003 Feb; 81(1):52-8. PubMed ID: 12534946 [TBL] [Abstract][Full Text] [Related]
34. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant. Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674 [TBL] [Abstract][Full Text] [Related]
35. Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine. Endmann A; Klünder K; Kapp K; Riede O; Oswald D; Talman EG; Schroff M; Kleuss C; Ruiters MH; Juhls C PLoS One; 2014; 9(7):e101715. PubMed ID: 24992038 [TBL] [Abstract][Full Text] [Related]
36. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge. Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890 [TBL] [Abstract][Full Text] [Related]
37. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice. Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361 [TBL] [Abstract][Full Text] [Related]
38. Cationic polymers that enhance the performance of HbsAg DNA in vivo. Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694 [TBL] [Abstract][Full Text] [Related]
39. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes. Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267 [TBL] [Abstract][Full Text] [Related]
40. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]